BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16618401)

  • 41. The Long-Term Predictive Properties of the Paris Classification in Paediatric Inflammatory Bowel Disease Patients.
    Assa A; Rinawi F; Shamir R
    J Crohns Colitis; 2018 Jan; 12(1):39-47. PubMed ID: 28961726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis.
    Melmed GY; Fleshner PR; Bardakcioglu O; Ippoliti A; Vasiliauskas EA; Papadakis KA; Dubinsky M; Landers C; Rotter JI; Targan SR
    Dis Colon Rectum; 2008 Jan; 51(1):100-8. PubMed ID: 18085333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
    Schwartz DA; White CM; Wise PE; Herline AJ
    Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating the impact of infliximab use on surgical outcomes in pediatric Crohn's disease.
    Abbas PI; Peterson ML; Fallon SC; Lopez ME; Wesson DE; Walsh SM; Kellermayer R; Rodriguez JR
    J Pediatr Surg; 2016 May; 51(5):786-9. PubMed ID: 26944181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors associated with progression to surgery in Crohn's disease patients with endoscopic stricture.
    Mao R; Chen BL; He Y; Cui Y; Zeng ZR; Chen MH
    Endoscopy; 2014 Nov; 46(11):956-62. PubMed ID: 25325683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory bowel disease characteristics in Hispanic children in Texas.
    Hattar LN; Abraham BP; Malaty HM; Smith EO; Ferry GD
    Inflamm Bowel Dis; 2012 Mar; 18(3):546-54. PubMed ID: 21456045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

  • 49. Factors associated with surgery in patients with intra-abdominal fistulizing Crohn's disease.
    Yaari S; Benson A; Aviran E; Lev Cohain N; Oren R; Sosna J; Israeli E
    World J Gastroenterol; 2016 Dec; 22(47):10380-10387. PubMed ID: 28058018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn's Disease Patients Treated With Combined Immunosuppressive Therapy.
    Kang B; Choi SY; Choi YO; Kim MJ; Kim K; Lee JH; Choe YH
    J Crohns Colitis; 2018 May; 12(6):644-652. PubMed ID: 29474531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
    Kristensen VA; Cvancarova M; Høivik ML; Moum B; Vatn MH
    Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
    [No Abstract]   [Full Text] [Related]  

  • 52. The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent.
    Goodhand JR; Kamperidis N; Joshi NM; Wahed M; Koodun Y; Cantor EJ; Croft NM; Langmead FL; Lindsay JO; Rampton DS
    Aliment Pharmacol Ther; 2012 Apr; 35(8):929-40. PubMed ID: 22404452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
    Charpentier C; Salleron J; Savoye G; Fumery M; Merle V; Laberenne JE; Vasseur F; Dupas JL; Cortot A; Dauchet L; Peyrin-Biroulet L; Lerebours E; Colombel JF; Gower-Rousseau C
    Gut; 2014 Mar; 63(3):423-32. PubMed ID: 23408350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.
    Cosnes J; Nion-Larmurier I; Beaugerie L; Afchain P; Tiret E; Gendre JP
    Gut; 2005 Feb; 54(2):237-41. PubMed ID: 15647188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease.
    Jose FA; Garnett EA; Vittinghoff E; Ferry GD; Winter HS; Baldassano RN; Kirschner BS; Cohen SA; Gold BD; Abramson O; Heyman MB
    Inflamm Bowel Dis; 2009 Jan; 15(1):63-8. PubMed ID: 18626963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regional differences in anti-TNF-α therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study.
    Lirhus SS; Høivik ML; Moum B; Melberg HO
    Scand J Gastroenterol; 2018 Aug; 53(8):952-957. PubMed ID: 30205699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation.
    Somineni HK; Venkateswaran S; Kilaru V; Marigorta UM; Mo A; Okou DT; Kellermayer R; Mondal K; Cobb D; Walters TD; Griffiths A; Noe JD; Crandall WV; Rosh JR; Mack DR; Heyman MB; Baker SS; Stephens MC; Baldassano RN; Markowitz JF; Dubinsky MC; Cho J; Hyams JS; Denson LA; Gibson G; Cutler DJ; Conneely KN; Smith AK; Kugathasan S
    Gastroenterology; 2019 Jun; 156(8):2254-2265.e3. PubMed ID: 30779925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis.
    Tung J; Loftus EV; Freese DK; El-Youssef M; Zinsmeister AR; Melton LJ; Harmsen WS; Sandborn WJ; Faubion WA
    Inflamm Bowel Dis; 2006 Dec; 12(12):1093-100. PubMed ID: 17119382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
    Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L
    Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.